Jarlego, Cliff S.

HRN: 23 23 12  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/08/2023
07/16/2023
IV
4.5gm
QID
Pneumonia High Risk
Checking Final Appropriateness 

Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: